vs
Side-by-side financial comparison of DaVita (DVA) and OLD REPUBLIC INTERNATIONAL CORP (ORI). Click either name above to swap in a different company.
DaVita is the larger business by last-quarter revenue ($3.6B vs $2.4B, roughly 1.5× OLD REPUBLIC INTERNATIONAL CORP). OLD REPUBLIC INTERNATIONAL CORP runs the higher net margin — 13.8% vs 6.5%, a 7.3% gap on every dollar of revenue. On growth, DaVita posted the faster year-over-year revenue change (12.3% vs 6.7%). Over the past eight quarters, OLD REPUBLIC INTERNATIONAL CORP's revenue compounded faster (13.2% CAGR vs 6.6%).
DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
Old Republic International Corporation is an American property insurance and title insurance company. The company is headquartered in Chicago, Illinois.
DVA vs ORI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.6B | $2.4B |
| Net Profit | $234.2M | $330.0M |
| Gross Margin | — | — |
| Operating Margin | 15.5% | — |
| Net Margin | 6.5% | 13.8% |
| Revenue YoY | 12.3% | 6.7% |
| Net Profit YoY | 43.8% | — |
| EPS (diluted) | $3.22 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $3.6B | $2.4B | ||
| Q4 25 | $3.6B | $2.4B | ||
| Q3 25 | $3.4B | $2.4B | ||
| Q2 25 | $3.4B | $2.2B | ||
| Q1 25 | $3.2B | $2.1B | ||
| Q4 24 | $3.3B | $2.0B | ||
| Q3 24 | $3.3B | $2.3B | ||
| Q2 24 | $3.2B | $1.9B |
| Q1 26 | $234.2M | $330.0M | ||
| Q4 25 | $234.2M | $206.5M | ||
| Q3 25 | $150.3M | $279.5M | ||
| Q2 25 | $199.3M | $204.4M | ||
| Q1 25 | $162.9M | $245.0M | ||
| Q4 24 | $259.3M | $105.3M | ||
| Q3 24 | $214.7M | $338.9M | ||
| Q2 24 | $222.7M | $91.8M |
| Q1 26 | 15.5% | — | ||
| Q4 25 | 15.5% | — | ||
| Q3 25 | 14.8% | 14.6% | ||
| Q2 25 | 15.9% | 11.8% | ||
| Q1 25 | 13.6% | 14.6% | ||
| Q4 24 | 17.2% | — | ||
| Q3 24 | 16.4% | 18.2% | ||
| Q2 24 | 15.9% | 6.1% |
| Q1 26 | 6.5% | 13.8% | ||
| Q4 25 | 6.5% | 8.6% | ||
| Q3 25 | 4.4% | 11.5% | ||
| Q2 25 | 5.9% | 9.3% | ||
| Q1 25 | 5.1% | 11.6% | ||
| Q4 24 | 7.9% | 5.3% | ||
| Q3 24 | 6.6% | 14.5% | ||
| Q2 24 | 7.0% | 4.9% |
| Q1 26 | $3.22 | — | ||
| Q4 25 | $3.22 | $0.82 | ||
| Q3 25 | $2.04 | $1.11 | ||
| Q2 25 | $2.58 | $0.81 | ||
| Q1 25 | $2.00 | $0.98 | ||
| Q4 24 | $3.08 | $0.42 | ||
| Q3 24 | $2.50 | $1.32 | ||
| Q2 24 | $2.50 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $700.7M | — |
| Total DebtLower is stronger | $10.2B | — |
| Stockholders' EquityBook value | $-651.1M | $5.9M |
| Total Assets | $17.5B | $29.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $700.7M | — | ||
| Q4 25 | $700.7M | — | ||
| Q3 25 | $736.5M | — | ||
| Q2 25 | $739.4M | — | ||
| Q1 25 | $511.9M | — | ||
| Q4 24 | $846.0M | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $437.2M | — |
| Q1 26 | $10.2B | — | ||
| Q4 25 | $10.2B | — | ||
| Q3 25 | $10.2B | — | ||
| Q2 25 | $10.1B | — | ||
| Q1 25 | $9.6B | — | ||
| Q4 24 | $9.2B | — | ||
| Q3 24 | $9.3B | — | ||
| Q2 24 | $8.5B | — |
| Q1 26 | $-651.1M | $5.9M | ||
| Q4 25 | $-651.1M | $5.9B | ||
| Q3 25 | $-571.9M | $6.4B | ||
| Q2 25 | $-369.6M | $6.2B | ||
| Q1 25 | $-267.1M | $5.9B | ||
| Q4 24 | $121.1M | $5.6B | ||
| Q3 24 | $386.7M | $6.4B | ||
| Q2 24 | $632.9M | $6.0B |
| Q1 26 | $17.5B | $29.6M | ||
| Q4 25 | $17.5B | $29.9B | ||
| Q3 25 | $17.6B | $30.3B | ||
| Q2 25 | $17.5B | $29.3B | ||
| Q1 25 | $17.1B | $28.0B | ||
| Q4 24 | $17.3B | $27.8B | ||
| Q3 24 | $17.5B | $28.8B | ||
| Q2 24 | $17.0B | $27.5B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 75.76× | — | ||
| Q3 24 | 23.95× | — | ||
| Q2 24 | 13.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DVA
Segment breakdown not available.
ORI
| operating | $2.2B | 92% |
| net investment gains | $201.8M | 8% |
